A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Oriola Corporation operates in the Medical - Pharmaceuticals industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 2.2B | 2.2B | 1.8B | 1.6B | 1.6B | 1.7B |
| Net Income | -31M | -31M | -22M | -22M | - | 13M |
| EPS | $-0.17 | $-0.17 | $-0.12 | $-0.12 | $0.03 | $0.06 |
| Free Cash Flow | 68M | 68M | 42M | 10M | 82M | 47M |
| ROIC | 0.2% | 5.5% | 21.8% | -5.0% | 3.9% | 4.8% |
| Gross Margin | - | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.69 | 0.30 | 0.04 | 0.31 | 0.57 |
| Dividends/Share | $0.08 | $0.08 | $0.08 | $0.07 | $0.06 | $0.05 |
| Operating Income | 2.9M | 2.9M | 15M | -5.8M | 10M | 13M |
| Operating Margin | 0.1% | 0.1% | 0.8% | -0.4% | 0.6% | 0.7% |
| ROE | -27.0% | -23.8% | -13.2% | -10.6% | - | 5.9% |
| Shares Outstanding | 181M | 181M | 183M | 188M | - | 226M |
| Metric | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1.9B | 2.1B | 1.7B | 1.6B | 1.6B | 1.8B | 2.2B | 2.2B |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 17M | 23M | 13M | 10M | -5.8M | 15M | 2.9M | 2.9M |
| Op. Margin | 0.9% | 1.1% | 0.7% | 0.6% | -0.4% | 0.8% | 0.1% | 0.1% |
| Net Income | 9.0M | 13M | 13M | N/A | -22M | -22M | -31M | -31M |
| Net Margin | 0.5% | 0.6% | 0.8% | N/A | -1.4% | -1.2% | -1.4% | -1.4% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||
| ROIC | 5.8% | 9.8% | 4.8% | 3.9% | -5.0% | 21.8% | 5.5% | 0.2% |
| ROE | 5.1% | 7.0% | 5.9% | N/A | -10.6% | -13.2% | -23.8% | -27.0% |
| ROA | 0.8% | 1.0% | 1.0% | N/A | -2.2% | -2.2% | -3.1% | -2.9% |
| Cash Flow | ||||||||
| Op. Cash Flow | 94M | 67M | 47M | 82M | 10M | 42M | 68M | 68M |
| Free Cash Flow | 94M | 67M | 47M | 82M | 10M | 42M | 68M | 68M |
| Owner Earnings | 48M | 20M | -3.7M | 63M | -4.6M | 29M | 54M | 54M |
| CapEx | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Maint. CapEx | 47M | 47M | 51M | 19M | 15M | 13M | 14M | 14M |
| Growth CapEx | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0 |
| D&A | 47M | 47M | 51M | 19M | 15M | 13M | 14M | 14M |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||
| Dividends Paid | 18M | 19M | 6.4M | 7.7M | 12M | 14M | 14M | 14M |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | 6.2% | 8.3% |
| Share Buybacks | 112K | 115K | 118K | 105K | 109K | 108K | 113K | 113K |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Balance Sheet | ||||||||
| Net Debt | 59M | -46M | 17M | -96M | -143M | -80M | -93M | -172M |
| Cash & Equiv. | 79M | 193M | 129M | 169M | 150M | 123M | 172M | 172M |
| Long-Term Debt | 138M | 147M | 146M | 74M | 7.7M | 43M | 43M | 43M |
| Debt/Equity | 0.79 | 0.75 | 0.57 | 0.31 | 0.04 | 0.30 | 0.69 | 0.00 |
| Interest Coverage | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | 176M | 195M | 256M | 238M | 186M | 144M | 114M | 114M |
| Total Assets | 1.2B | 1.3B | 1.3B | 1.0B | 1.0B | 946M | 1.1B | 1.1B |
| Total Liabilities | 977M | 1.1B | 1.0B | 774M | 829M | 802M | 957M | 957M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | 11M | 8.8M | 8.8M |
| Retained Earnings | 67M | 63M | 104M | 88M | 55M | 20M | -23M | -23M |
| Working Capital | -220M | -237M | -199M | -112M | -165M | -136M | -151M | -151M |
| Current Assets | 583M | 722M | 654M | 570M | 637M | 607M | 744M | 744M |
| Current Liabilities | 803M | 958M | 853M | 682M | 802M | 743M | 894M | 894M |
| Per Share Data | ||||||||
| EPS | 0.04 | 0.07 | 0.06 | 0.03 | -0.12 | -0.12 | -0.17 | -0.17 |
| Owner EPS | 0.24 | 0.10 | -0.02 | N/A | -0.02 | 0.16 | 0.30 | 0.30 |
| Book Value | 0.88 | 1.03 | 1.13 | N/A | 0.99 | 0.79 | 0.63 | 0.63 |
| Cash Flow/Share | 0.47 | 0.36 | 0.21 | N/A | 0.06 | 0.23 | 0.37 | -0.09 |
| Dividends/Share | 0.09 | 0.03 | 0.05 | 0.06 | 0.07 | 0.08 | 0.08 | 0.08 |
| Shares Out. | 200.0M | 188.3M | 226.0M | N/A | 188.2M | 182.7M | 181.3M | 181.3M |
| Valuation | ||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | -7.6 | -5.6 |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | 3.4 | 2.5 |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | 47.4 | 0.1 |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | 2.0 | 1.5 |
| Price/Sales | N/A | N/A | N/A | N/A | N/A | N/A | 0.1 | 0.1 |
| FCF Yield | N/A | N/A | N/A | N/A | N/A | N/A | 29.2% | 39.4% |
| Market Cap | 0 | 0 | 0 | 0 | 0 | 0 | 233M | 172M |
| Avg. Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.28 | 0.95 |
| Year-End Price | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.28 | 0.95 |
Oriola Corporation passes 2 of 9 quality checks, indicating weak fundamentals.
On a free-cash-flow basis, the stock trades at 2.5x vs a median of 3.4x. The company's 5-year average ROIC is 6.2%. Total shareholder yield (dividends) is 8.4%.
Oriola Corporation (ORIOLA-HE) has a 5-year average return on invested capital (ROIC) of 6.2%. This is below average and may indicate limited pricing power.
Oriola Corporation (ORIOLA-HE) has a market capitalization of $172M. It is classified as a small-cap stock.
Yes, Oriola Corporation (ORIOLA-HE) pays a dividend with a trailing twelve-month yield of 8.34%. The company also returns capital through share buybacks, with a buyback yield of 0.07%.
Oriola Corporation (ORIOLA-HE) operates in the Medical - Pharmaceuticals industry, within the Healthcare sector.
Oriola Corporation (ORIOLA-HE) reported annual revenue of $2.2 billion in its most recent fiscal year, based on SEC EDGAR filings.
Oriola Corporation (ORIOLA-HE) has a net profit margin of -1.4%. The company is currently unprofitable.
Oriola Corporation (ORIOLA-HE) generated $68 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Oriola Corporation (ORIOLA-HE) has a debt-to-equity ratio of 0.69. This indicates moderate leverage.
Oriola Corporation (ORIOLA-HE) reported earnings per share (EPS) of $-0.17 in its most recent fiscal year.
Oriola Corporation (ORIOLA-HE) has a return on equity (ROE) of -23.8%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 7 years of financial data for Oriola Corporation (ORIOLA-HE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Oriola Corporation (ORIOLA-HE) has a book value per share of $0.63, based on its most recent annual SEC filing.